
### [MONDO:0006856](http://purl.obolibrary.org/obo/MONDO_0006856)
**Label:** mesothelial neoplasm

**Subclasses:** [MONDO:0003805](http://purl.obolibrary.org/obo/MONDO_0003805) (malignant pericardial mesothelioma), [MONDO:0003308](http://purl.obolibrary.org/obo/MONDO_0003308) (pleural mesothelioma), [MONDO:0003328](http://purl.obolibrary.org/obo/MONDO_0003328) (fallopian tube adenomatoid tumor), [MONDO:0003688](http://purl.obolibrary.org/obo/MONDO_0003688) (benign intermediate mesothelioma), [MONDO:0002112](http://purl.obolibrary.org/obo/MONDO_0002112) (benign peritoneal mesothelioma), [MONDO:0001781](http://purl.obolibrary.org/obo/MONDO_0001781) (uterine corpus adenomatoid tumor), [MONDO:0006378](http://purl.obolibrary.org/obo/MONDO_0006378) (pleural epithelioid mesothelioma), [MONDO:0006377](http://purl.obolibrary.org/obo/MONDO_0006377) (pleural biphasic mesothelioma), [MONDO:0006674](http://purl.obolibrary.org/obo/MONDO_0006674) (benign fibrous mesothelioma), [MONDO:0004230](http://purl.obolibrary.org/obo/MONDO_0004230) (adenomatoid tumor), [MONDO:0002373](http://purl.obolibrary.org/obo/MONDO_0002373) (benign mesothelioma), [MONDO:0005065](http://purl.obolibrary.org/obo/MONDO_0005065) (mesothelioma), [MONDO:0006292](http://purl.obolibrary.org/obo/MONDO_0006292) (malignant mesothelioma (disease)), [MONDO:0006407](http://purl.obolibrary.org/obo/MONDO_0006407) (sarcomatoid mesothelioma), [MONDO:0004227](http://purl.obolibrary.org/obo/MONDO_0004227) (epididymis adenomatoid tumor), [MONDO:0004205](http://purl.obolibrary.org/obo/MONDO_0004205) (lymphohistiocytoid mesothelioma), [MONDO:0006109](http://purl.obolibrary.org/obo/MONDO_0006109) (malignant biphasic mesothelioma), [MONDO:0005512](http://purl.obolibrary.org/obo/MONDO_0005512) (malignant peritoneal mesothelioma), [MONDO:0002223](http://purl.obolibrary.org/obo/MONDO_0002223) (ovarian malignant mesothelioma), [MONDO:0005599](http://purl.obolibrary.org/obo/MONDO_0005599) (malignant epithelioid mesothelioma), [MONDO:0005112](http://purl.obolibrary.org/obo/MONDO_0005112) (malignant pleural mesothelioma), [MONDO:0006364](http://purl.obolibrary.org/obo/MONDO_0006364) (peritoneal well differentiated papillary mesothelioma), [MONDO:0006363](http://purl.obolibrary.org/obo/MONDO_0006363) (peritoneal multicystic mesothelioma), [MONDO:0006362](http://purl.obolibrary.org/obo/MONDO_0006362) (peritoneal mesothelioma (disease)), [MONDO:0006380](http://purl.obolibrary.org/obo/MONDO_0006380) (pleural sarcomatoid mesothelioma), 

**Mapped go classes:** [GO:0039022](http://purl.obolibrary.org/obo/GO_0039022) (pronephric duct development), [GO:0061032](http://purl.obolibrary.org/obo/GO_0061032) (visceral serous pericardium development), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0039021](http://purl.obolibrary.org/obo/GO_0039021) (pronephric glomerulus development), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0042101](http://purl.obolibrary.org/obo/GO_0042101) (T cell receptor complex), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0048793](http://purl.obolibrary.org/obo/GO_0048793) (pronephros development), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0032449](http://purl.obolibrary.org/obo/GO_0032449) (CBM complex), [GO:0032835](http://purl.obolibrary.org/obo/GO_0032835) (glomerulus development), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0046696](http://purl.obolibrary.org/obo/GO_0046696) (lipopolysaccharide receptor complex), [GO:0072112](http://purl.obolibrary.org/obo/GO_0072112) (glomerular visceral epithelial cell differentiation), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0072149](http://purl.obolibrary.org/obo/GO_0072149) (glomerular visceral epithelial cell fate commitment), [GO:0030325](http://purl.obolibrary.org/obo/GO_0030325) (adrenal gland development), 

**Class expressions from DL-Learner:**

- [GO:0061032](http://purl.obolibrary.org/obo/GO_0061032) (visceral serous pericardium development) 58.33%
- [GO:0046696](http://purl.obolibrary.org/obo/GO_0046696) (lipopolysaccharide receptor complex) 58.33%
- [GO:0039022](http://purl.obolibrary.org/obo/GO_0039022) (pronephric duct development) 58.33%
- [GO:0039021](http://purl.obolibrary.org/obo/GO_0039021) (pronephric glomerulus development) 58.33%
- [GO:0032835](http://purl.obolibrary.org/obo/GO_0032835) (glomerulus development) 58.33%
- [GO:0032449](http://purl.obolibrary.org/obo/GO_0032449) (CBM complex) 58.33%
- [GO:0030325](http://purl.obolibrary.org/obo/GO_0030325) (adrenal gland development) 58.33%
- Thing 51.57%
- [GO:0072176](http://purl.obolibrary.org/obo/GO_0072176) (nephric duct development) 43.69%
- [GO:0048856](http://purl.obolibrary.org/obo/GO_0048856) (anatomical structure development) 38.98%
- [GO:0032502](http://purl.obolibrary.org/obo/GO_0032502) (developmental process) 36.91%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 34.96%
- [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex) 20.46%
- [GO:0032991](http://purl.obolibrary.org/obo/GO_0032991) (macromolecular complex) 20.34%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 19.29%


